Welcome to Business Insider‘s daily healthcare newsletter, your daily dose of pharma, biotech, and healthcare news. Subscribe here to get this newsletter in your inbox every weekday.
Today in healthcare news: The pitch deck that convinced J&J to bet on a new kind of healthcare company, Pfizer plans to submit its vaccine in November for emergency authorization if it works, and an inside look at how Gilead developed remdesivir, a drug that now faces questions about how effective it is in treating COVID-19.
See the pitch deck 2 former Googlers used to raise $47 million and convince Johnson & Johnson to bet on the hottest part of healthcare
Xinhua/Gil Cohen Magen via Getty Images
Pfizer plans to submit its COVID-19 vaccine for FDA authorization in late November — if human trials show it works
Here’s how the biotech giant Gilead created the leading coronavirus drug remdesivir, which now faces questions over its effectiveness at treating COVID-19
More stories we’re reading: